Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,024
NCT00418145
Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 30, 2003
Completion: Oct 31, 2013
NCT00211887
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
Start: Jan 31, 2005
Completion: Mar 31, 2013